Effects of A1 versus A2 milk on cardiometabolic risk in overweight and obese Australians

Not Applicable

Recruiting

• Conditions: Overweight and obesity; Cardiometabolic risk factors related to A1 beta-casein; Gastrointestinal symptoms related to A1 beta-casein; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system; Diet and Nutrition - Obesity; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12617000403336
• Lead Sponsor: Curtin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-17
• Last Update Posted: 3 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

overweight or obese (BMI: 25-40 kg/m2)
willing to consume 750 ml of milk/day

Exclusion Criteria

Milk allergy, pregnancy and lactation, diabetes, current habitual opioid consumption and smokers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting serum cholesterol[Pre-washout, baseline and 12 weeks.];Fasting serum triglyceride[Pre-washout, baseline and 12 weeks.];Antibodies to oxidised LDL measured by ELISA[Pre-washout, baseline and 12 weeks.]